Somatostatin may enhance cytotoxic effect of doxorubicin on gallbladder cancer cells

Chinese Journal of Cancer Research

Volumn 16, Issue 4, 2004, Pages 265-268

  Li, Ji Yu ^a,c   Quan, Zhi Wei ^a   Zhang, Qiang ^b   Liu, Jian Wen ^b  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell cycle; Chemosensitivity; DOX; Gallbladder cancer; Somatostatin

Indexed keywords

DOXORUBICIN; SOMATOSTATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CELL CYCLE; CELL VIABILITY; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; GALLBLADDER CANCER; HUMAN; HUMAN CELL; IC 50; REGULATORY MECHANISM;

EID: 12344262664     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-004-0040-8     Document Type: Article

References (8)

1. Grobmyer SR, Lieberman MD, Daly JM. Gallbladder cancer in the twentieth century: single institution's experience[J]. World J Surg 2004; 28: 47-9.
2. Todoroki T. chemotherapy for gallbladder carcinoma - a surgeon's perspective[J]. Hepatogastroenterology 2000; 47: 948-55.
3. Misra S, Chaturvedi A, Misra NC, et al. carcinoma of the gallbladder[J]. Lancet Oncol 2003; 4: 167-76.
4. Jacks T, Weinberg RA. Cell cycle control and its watchman[J]. Nature 1996; 381: 643.
5. Buscail L, Vernejoul F, Faure P, et al. Regulation of cell proliferation by somatostatin[J]. Ann Endocrinol (Paris), 2002; 63: 2S13-2S18.
6. Dong ZHW, Yu YM, Jian WL. Quantification of doxorubicin and validation of reversal effect of tea polyphenols on multidrug resistance in human carcinoma cells[J]. Biotechnol Lett 2003; 25: 291-4.
7. Kigawa J, Sato S, Shimada M, et al. p53 gene status and chemosensitivity in ovarian cancer[J]. Hum Cell 2001; 14: 165-71.
8. Sharma K, Srikant CB. Induction of wild-[type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells[J]. Int J Cancer 1998; 76: 259-266.